[Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA)].
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D001007:Anxiety / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology*; D003430:Cross-Sectional Studies; D003863:Depression / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D005602:France / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D018451:Homosexuality, Male / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D019966:Substance-Related Disorders / Q000453:epidemiology; D011795:Surveys and Questionnaires
Anhédonie et dépression dans le contexte de l'infection par le VIH avec les multithérapies antirétrovirales (ANRS-EN12-VESPA).